IBC Drug & Alcohol Testing Branch Quarterly Newsletter - FY 2019 Q4

DOI Interior Business Center sent this bulletin at 09/24/2019 11:03 AM EDT

U.S. Department of the Interior
Interior Business Center
doi.gov/IBC

Cannabidiol (CBD)

CBD continues to be a topic of discussion

We addressed the usage of CBD in a previous newsletter but it continues to be a topic of discussion. SAMHSA’s addressed recent concerns with a memo. The FDA has posted an article What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD.

Waiting on Paperwork Status

How to get a result to post faster

All donors (applicants and employees), receive a copy of the Federal Drug Testing Custody and Control Form (CCF). When notifying a donor to take a drug test tell them to press hard with their pen on this carbon paper when filling it out at the collection site and then providing you with a copy afterwards. If the result goes into Waiting on Paperwork status in eDrug, you can fax a copy of the paperwork to the Medical Review Office (fax # is in the top right corner of the CCF).

eCCF initiative

Why is drug testing still relying on paper in 2019?

Paper was the only regulated option for drug testing until HHS’ SAMHSA allowed for electronic CCFs. IBC is in workings with our provider, Abbott (formerly eScreen, Alere, or Pembrooke Occupational Health) to drastically reduce our reliance on paper CCF process and introduce eCCF to all customers. More to come on this project in FY2020.

The Interior Business Center is a federal shared services provider that operates under a fee-for-service, full cost recovery business model, offering Acquisition, Financial Management and Human Resources systems and services to federal organizations.

Having trouble viewing this email? View it as a Web page.

DOI - Interior Business Center | 1849 C Street, NW - MS 1748 | Washington | DC | 20240